Cineverse (NASDAQ:CNVS – Free Report) had its target price lifted by Benchmark from $9.00 to $10.00 in a research note released on Friday,Benzinga reports. They currently have a speculative buy rating on the stock.
Separately, Alliance Global Partners boosted their price target on shares of Cineverse from $4.00 to $4.50 and gave the stock a “buy” rating in a research note on Tuesday, October 22nd.
Check Out Our Latest Analysis on CNVS
Cineverse Trading Up 23.1 %
Institutional Trading of Cineverse
A hedge fund recently raised its stake in Cineverse stock. Corsair Capital Management L.P. grew its stake in shares of Cineverse Corp. (NASDAQ:CNVS – Free Report) by 86.6% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 617,159 shares of the company’s stock after purchasing an additional 286,507 shares during the period. Corsair Capital Management L.P. owned approximately 3.93% of Cineverse worth $604,000 at the end of the most recent reporting period. 8.19% of the stock is currently owned by institutional investors.
About Cineverse
Cineverse Corp. operates as a streaming technology and entertainment company. The company operates in two segments, Cinema Equipment, and Content and Entertainment. It owns and operates streaming channels, through its proprietary technology platform. The company also delivers curated content through subscription video on demand (SVOD), dedicated ad-supported (AVOD), and ad-supported streaming linear (FAST) channels, as well as social video streaming services and audio podcasts; operates OTT streaming entertainment channels; and offers monitoring, billing, collection, and verification services.
Further Reading
- Five stocks we like better than Cineverse
- What Are Some of the Best Large-Cap Stocks to Buy?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What is the Nikkei 225 index?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Cineverse Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cineverse and related companies with MarketBeat.com's FREE daily email newsletter.